Long-term outcomes of PDS appear comparable to monthly ranibizumab injections

End-of-study results for the extension phase of the phase 2 Ladder trial, comparing use of the Port Delivery System (PDS) and monthly intravitreal injections of ranibizumab for neovascular AMD, suggest comparable efficacy outcomes.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553